» Articles » PMID: 28244124

Visceral Adiposity Predicts Post-operative Crohn's Disease Recurrence

Overview
Date 2017 Mar 1
PMID 28244124
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease.

Aim: To determine whether body composition is associated with outcome in a prospective study of post-operative Crohn's disease patients.

Methods: The POCER study evaluated management strategies for prevention of post-operative Crohn's disease recurrence; subjects were enrolled after resection of all macroscopic Crohn's disease and were randomised to early endoscopy and possible treatment escalation, or standard care. The primary endpoint was endoscopic recurrence at 18 months. 44 subjects with cross-sectional abdominal imaging were studied, and body composition analysis performed using established techniques to measure visceral adipose tissue area, subcutaneous adipose tissue area, and skeletal muscle area.

Results: The body composition parameter with the greatest variance was visceral adipose tissue. Regardless of treatment, all subjects with visceral adipose tissue/height >1.5 times the gender-specific mean experienced endoscopic recurrence at 18 months (compared to 47%) [relative risk 2.1, 95% CI 1.5-3.0, P = 0.012]. Waist circumference correlated strongly with visceral adipose tissue area (ρ = 0.840, P < 0.001). Low skeletal muscle was prevalent (41% of patients), but did not predict endoscopic recurrence; however, appendicular skeletal muscle indices correlated inversely with faecal calprotectin (ρ = 0.560, P = 0.046).

Conclusions: Visceral adiposity is an independent risk factor for endoscopic recurrence of Crohn's disease after surgery. Sarcopenia correlates with inflammatory biomarkers. Measures of visceral adipose tissue may help to stratify risk in post-operative management strategies.

Citing Articles

To cut or not to cut? Extended mesenteric excision during intestinal resection does not impact the postoperative recurrence nor the postoperative complications in Crohn's disease: a systematic review and meta-analysis.

Topala M, Martinekova P, Rancz A, Veres D, Lenti K, Miheller P Tech Coloproctol. 2025; 29(1):79.

PMID: 40057619 PMC: 11890256. DOI: 10.1007/s10151-025-03110-w.


Extended mesenteric resection reduces the rate of surgical recurrence in Crohn's disease: a systematic review and meta-analysis.

Vaghiri S, Alipouriani A, Knoefel W, Kessler H, Prassas D Int J Colorectal Dis. 2025; 40(1):51.

PMID: 39998692 PMC: 11861228. DOI: 10.1007/s00384-025-04845-6.


The mesenteric adipokine SFRP5 alleviated intestinal epithelial apoptosis improving barrier dysfunction in Crohn's disease.

Zhang X, Zuo L, Song X, Zhang W, Yang Z, Wang Z iScience. 2025; 27(12):111517.

PMID: 39759008 PMC: 11699250. DOI: 10.1016/j.isci.2024.111517.


Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.

Xie C, Qian W, Shang L, Wang X, Zhang J, Ma X Am J Transl Res. 2024; 16(10):5427-5440.

PMID: 39544770 PMC: 11558411. DOI: 10.62347/ZPZR8134.


Detecting and characterizing creeping fat in Crohn's disease: agreement between intestinal ultrasound and computed tomography enterography.

Zhou M, Niu Z, Ma L, Li W, Xiao M, He Y Insights Imaging. 2024; 15(1):229.

PMID: 39312060 PMC: 11420403. DOI: 10.1186/s13244-024-01807-4.